"ERA specializes in Phase I-IV clinical research studies. We service both pharmaceuticals and medical devices."

During the past decade, Eastside Research Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastside Research Associates" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Abbott Diabetes Care" with 1 trials sponsored, "Adamis Pharmaceuticals Corporation" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Pine Trees, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastside Research Associates" #1 collaborator was "Eastside Research Associates" with 3 trials as a collaborator, "ASCLEPES Research Center" with 2 trials as a collaborator, "MRI Global" with 2 trials as a collaborator, "DuPage Medical Group" with 1 trials as a collaborator and "HealthMinds" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Eastside Research Associates" are "COVID-19" (2 trials), "Covid19" (2 trials), "Asymptomatic COVID-19" (1 trials), "Diabetes Mellitus" (1 trials) and "No Specific Medical Conditions or Disease States" (1 trials). Many other conditions were trialed in "Eastside Research Associates" in a lesser frequency.

Most popular intervention types in "Eastside Research Associates" are "Drug" (4 trials), "Diagnostic Test" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Continuous monitoring through Dozee VS" (1 trials), "Continuous monitoring through Earlysense" (1 trials), "Dulaglutide" (1 trials) and "HBA1c data and glucose levels" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eastside Research Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Eastside Research Associates". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Eastside Research Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eastside Research Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".